Synthetic biology aims to make the engineering of complex biological functions more efficient, reliable and predictable.
Recent developments in engineering mammalian cells, on the basis of novel tools such as programmable transcription factors, RNA-based control devices, optogenetic methods and engineered proteins, enable rerouting signalling pathways.
High-throughput analysis of synthetic DNA elements and site-directed targeting of chromatin modifiers have revealed insights into gene regulation by sequence- and chromatin-based mechanisms.
Analysis of synthetic circuits offers a novel approach to study natural gene networks and protein signalling pathways such as the T cell receptor signalling pathway and kinase cascades.
Synthetic biology approaches are helping to improve the specificity of the delivery and activity of therapeutic agents for gene and protein therapies.
Enhanced efficiency and safety of engineered systems are leading to exciting therapeutic approaches such as chimeric antigen receptors, microencapsulation of cell-based metabolic control devices and RNA-based vaccines.
Recent progress in DNA manipulation and gene circuit engineering has greatly improved our ability to programme and probe mammalian cell behaviour. These advances have led to a new generation of synthetic biology research tools and potential therapeutic applications. Programmable DNA-binding domains and RNA regulators are leading to unprecedented control of gene expression and elucidation of gene function. Rebuilding complex biological circuits such as T cell receptor signalling in isolation from their natural context has deepened our understanding of network motifs and signalling pathways. Synthetic biology is also leading to innovative therapeutic interventions based on cell-based therapies, protein drugs, vaccines and gene therapies.
Subscribe to Journal
Get full journal access for 1 year
only $8.25 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Endy, D. Foundations for engineering biology. Nature 438, 449–453 (2005).
Knight, T. DARPA BioComp Plasmid Distribution 1.00 of Standard Biobrick Components. MIT Synthet. Biol. Work. Group Rep. (2002).
Mutalik, V. K. et al. Precise and reliable gene expression via standard transcription and translation initiation elements. Nature Methods 10, 354–360 (2013).
Gardner, T. S., Cantor, C. R. & Collins, J. J. Construction of a genetic toggle switch in Escherichia coli. Nature 403, 339–342 (2000).
Elowitz, M. B. & Leibler, S. A synthetic oscillatory network of transcriptional regulators. Nature 403, 335–338 (2000).
Guet, C. C., Elowitz, M. B., Hsing, W. & Leibler, S. Combinatorial synthesis of genetic networks. Science 296, 1466–1470 (2002).
Khalil, A. S. & Collins, J. J. Synthetic biology: applications come of age. Nature Rev. Genet. 11, 367–379 (2010).
Brown, M. et al. Lac repressor can regulate expression from a hybrid SV40 early promoter containing a lac operator in animal cells. Cell 49, 603–612 (1987).
Gossen, M. & Bujard, H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl Acad. Sci. USA 89, 5547–5551 (1992).
Maeder, M. L. et al. Rapid “open-source” engineering of customized zinc-finger nucleases for highly efficient gene modification. Mol. Cell 31, 294–301 (2008).
Boch, J. et al. Breaking the code of DNA binding specificity of TAL-type III effectors. Science 326, 1509–1512 (2009).
Moscou, M. J. & Bogdanove, A. J. A simple cipher governs DNA recognition by TAL effectors. Science 326, 1501 (2009). References 11 and 12 describe how the DNA-binding specificity of TALEs is determined.
Morbitzer, R., Romer, P., Boch, J. & Lahaye, T. Regulation of selected genome loci using de novo-engineered transcription activator-like effector (TALE)-type transcription factors. Proc. Natl Acad. Sci. USA 107, 21617–21622 (2010).
Garg, A., Lohmueller, J. J., Silver, P. A. & Armel, T. Z. Engineering synthetic TAL effectors with orthogonal target sites. Nucleic Acids Res. 40, 7584–7595 (2012).
Reyon, D. et al. FLASH assembly of TALENs for high-throughput genome editing. Nature Biotech. 30, 460–465 (2012).
Morbitzer, R., Elsaesser, J., Hausner, J. & Lahaye, T. Assembly of custom TALE-type DNA binding domains by modular cloning. Nucleic Acids Res. 39, 5790–5799 (2011).
Schmid-Burgk, J. L. et al. Rapid hierarchical assembly of medium-size DNA cassettes. Nucleic Acids Res. 40, e92 (2012).
Holkers, M. et al. Differential integrity of TALE nuclease genes following adenoviral and lentiviral vector gene transfer into human cells. Nucleic Acids Res. 41, e63 (2013).
Cong, L. et al. Multiplex genome engineering using CRISPR/Cas systems. Science 339, 819–823 (2013).
Jinek, M. et al. RNA-programmed genome editing in human cells. eLife 2, e00471 (2013).
Mali, P. et al. RNA-guided human genome engineering via Cas9. Science 339, 823–826 (2013). References 19–21 describe how the bacterial CRISPR system can be used for genome engineering in human cells.
Wang, H. et al. One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering. Cell 153, 910–918 (2013).
Qi, L. S. et al. Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression. Cell 152, 1173–1183 (2013).
Gilbert, L. A. et al. CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes. Cell 154, 442–451 (2013).
Maeder, M. L. et al. CRISPR RNA-guided activation of endogenous human genes. Nature Methods 10, 977–979 (2013).
Mali, P. et al. CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering. Nature Biotech. 31, 833–838 (2013).
Perez-Pinera, P. et al. RNA-guided gene activation by CRISPR–Cas9-based transcription factors. Nature Methods 10, 973–976 (2013).
Wehr, M. C. et al. Monitoring regulated protein–protein interactions using split TEV. Nature Methods 3, 985–993 (2006).
Xie, Z., Wroblewska, L., Prochazka, L., Weiss, R. & Benenson, Y. Multi-input RNAi-based logic circuit for identification of specific cancer cells. Science 333, 1307–1311 (2011). Reports the engineering of a circuit that integrates a combinatorial signal of six miRNAs for sensing a specific cancer cell type.
Li, Y., Moore, R., Guinn, M. & Bleris, L. Transcription activator-like effector hybrids for conditional control and rewiring of chromosomal transgene expression. Sci. Rep. 2, 897 (2012).
Whitfield, T. W. et al. Functional analysis of transcription factor binding sites in human promoters. Genome Biol. 13, R50 (2012).
Deans, T. L., Cantor, C. R. & Collins, J. J. A tunable genetic switch based on RNAi and repressor proteins for regulating gene expression in mammalian cells. Cell 130, 363–372 (2007).
Kemmer, C. et al. Self-sufficient control of urate homeostasis in mice by a synthetic circuit. Nature Biotech. 28, 355–360 (2010). Reports the implantation of encapsulated cells that were engineered to release urate oxidase in response to high levels of uric acid for controlling hyperuricemia.
Leisner, M., Bleris, L., Lohmueller, J., Xie, Z. & Benenson, Y. Rationally designed logic integration of regulatory signals in mammalian cells. Nature Nanotechnol. 5, 666–670 (2010).
Ye, H. et al. Pharmaceutically controlled designer circuit for the treatment of the metabolic syndrome. Proc. Natl Acad. Sci. USA 110, 141–146 (2013).
Polstein, L. R. & Gersbach, C. A. Light-inducible spatiotemporal control of gene activation by customizable zinc finger transcription factors. J. Am. Chem. Soc. 134, 16480–16483 (2012).
Konermann, S. et al. Optical control of mammalian endogenous transcription and epigenetic states. Nature 500, 472–476 (2013). Describes the development of a TALE-based, light-inducible system for controlling transcription and chromatin states in vitro and in vivo.
Crefcoeur, R. P., Yin, R., Ulm, R. & Halazonetis, T. D. Ultraviolet-B-mediated induction of protein-protein interactions in mammalian cells. Nature Commun. 4, 1779 (2013).
Muller, K. et al. Multi-chromatic control of mammalian gene expression and signaling. Nucleic Acids Res. 41, e124 (2013).
Kramer, B. P., Fischer, C. & Fussenegger, M. BioLogic gates enable logical transcription control in mammalian cells. Biotechnol. Bioeng. 87, 478–484 (2004).
Lohmueller, J. J., Armel, T. Z. & Silver, P. A. A tunable zinc finger-based framework for Boolean logic computation in mammalian cells. Nucleic Acids Res. 40, 5180–5187 (2012).
Auslander, S., Auslander, D., Muller, M., Wieland, M. & Fussenegger, M. Programmable single-cell mammalian biocomputers. Nature 487, 123–127 (2012).
Lienert, F. et al. Two- and three-input TALE-based AND logic computation in embryonic stem cells. Nucleic Acids Res. 41, 9967–9975 (2013).
Burrill, D. R., Inniss, M. C., Boyle, P. M. & Silver, P. A. Synthetic memory circuits for tracking human cell fate. Genes Dev. 26, 1486–1497 (2012).
Weber, W. et al. A synthetic time-delay circuit in mammalian cells and mice. Proc. Natl Acad. Sci. USA 104, 2643–2648 (2007).
Tigges, M., Marquez-Lago, T. T., Stelling, J. & Fussenegger, M. A tunable synthetic mammalian oscillator. Nature 457, 309–312 (2009).
Liang, J. C., Bloom, R. J. & Smolke, C. D. Engineering biological systems with synthetic RNA molecules. Mol. Cell 43, 915–926 (2011).
Win, M. N. & Smolke, C. D. Higher-order cellular information processing with synthetic RNA devices. Science 322, 456–460 (2008).
Culler, S. J., Hoff, K. G. & Smolke, C. D. Reprogramming cellular behavior with RNA controllers responsive to endogenous proteins. Science 330, 1251–1255 (2010). Describes splicing-based RNA control devices that detect endogenous protein inputs in a combinatorial manner.
Rinaudo, K. et al. A universal RNAi-based logic evaluator that operates in mammalian cells. Nature Biotech. 25, 795–801 (2007).
Ellington, A. D. & Szostak, J. W. In vitro selection of RNA molecules that bind specific ligands. Nature 346, 818–822 (1990).
Yen, H. C., Xu, Q., Chou, D. M., Zhao, Z. & Elledge, S. J. Global protein stability profiling in mammalian cells. Science 322, 918–923 (2008).
Hershko, A. & Ciechanover, A. The ubiquitin system. Annu. Rev. Biochem. 67, 425–479 (1998).
Nishimura, K., Fukagawa, T., Takisawa, H., Kakimoto, T. & Kanemaki, M. An auxin-based degron system for the rapid depletion of proteins in nonplant cells. Nature Methods 6, 917–922 (2009).
Bonger, K. M., Chen, L. C., Liu, C. W. & Wandless, T. J. Small-molecule displacement of a cryptic degron causes conditional protein degradation. Nature Chem. Biol. 7, 531–537 (2011).
Banaszynski, L. A., Chen, L. C., Maynard-Smith, L. A., Ooi, A. G. & Wandless, T. J. A rapid, reversible, and tunable method to regulate protein function in living cells using synthetic small molecules. Cell 126, 995–1004 (2006).
Renicke, C., Schuster, D., Usherenko, S., Essen, L. O. & Taxis, C. A. LOV2 domain-based optogenetic tool to control protein degradation and cellular function. Chem. Biol. 20, 619–626 (2013).
Dong, S., Rogan, S. C. & Roth, B. L. Directed molecular evolution of DREADDs: a generic approach to creating next-generation RASSLs. Nature Protoc. 5, 561–573 (2010).
Struhl, G. & Adachi, A. Nuclear access and action of notch in vivo. Cell 93, 649–660 (1998).
Barnea, G. et al. The genetic design of signaling cascades to record receptor activation. Proc. Natl Acad. Sci. USA 105, 64–69 (2008).
Howard, P. L., Chia, M. C., Del Rizzo, S., Liu, F. F. & Pawson, T. Redirecting tyrosine kinase signaling to an apoptotic caspase pathway through chimeric adaptor proteins. Proc. Natl Acad. Sci. USA 100, 11267–11272 (2003).
Lim, W. A. Designing customized cell signalling circuits. Nature Rev. Mol. Cell Biol. 11, 393–403 (2010).
Kapp, G. T. et al. Control of protein signaling using a computationally designed GTPase/GEF orthogonal pair. Proc. Natl Acad. Sci. USA 109, 5277–5282 (2012). Shows that the interaction domain of a GTPase and its activator can be reengineered to obtain a pair of orthogonal synthetic signalling proteins.
Reinke, A. W., Grant, R. A. & Keating, A. E. A synthetic coiled-coil interactome provides heterospecific modules for molecular engineering. J. Am. Chem. Soc. 132, 6025–6031 (2010).
Mootz, H. D., Blum, E. S., Tyszkiewicz, A. B. & Muir, T. W. Conditional protein splicing: a new tool to control protein structure and function in vitro and in vivo. J. Am. Chem. Soc. 125, 10561–10569 (2003).
Berrade, L., Kwon, Y. & Camarero, J. A. Photomodulation of protein trans-splicing through backbone photocaging of the DnaE split intein. Chembiochem 11, 1368–1372 (2010).
Selgrade, D. F., Lohmueller, J. J., Lienert, F. & Silver, P. A. Protein scaffold-activated protein trans-splicing in mammalian cells. J. Am. Chem. Soc. 135, 7713–7719 (2013).
Wend, S. et al. Optogenetic control of protein kinase activity in mammalian cells. ACS Synth. Biol. http://dx.doi.org/10.1021/sb400090s (2013).
Bugaj, L. J., Choksi, A. T., Mesuda, C. K., Kane, R. S. & Schaffer, D. V. Optogenetic protein clustering and signaling activation in mammalian cells. Nature Methods 10, 249–252 (2013).
Garcia-Otin, A. L. & Guillou, F. Mammalian genome targeting using site-specific recombinases. Front. Biosci. 11, 1108–1136 (2006).
Taniguchi, H. et al. A resource of Cre driver lines for genetic targeting of GABAergic neurons in cerebral cortex. Neuron 71, 995–1013 (2011).
Hirrlinger, J. et al. Split-cre complementation indicates coincident activity of different genes in vivo. PLoS ONE 4, e4286 (2009).
Wang, P. et al. Intersectional Cre driver lines generated using split-intein mediated split-Cre reconstitution. Sci. Rep. 2, 497 (2012).
Bibikova, M., Beumer, K., Trautman, J. K. & Carroll, D. Enhancing gene targeting with designed zinc finger nucleases. Science 300, 764 (2003).
Porteus, M. H. & Baltimore, D. Chimeric nucleases stimulate gene targeting in human cells. Science 300, 763 (2003).
Christian, M. et al. Targeting DNA double-strand breaks with TAL effector nucleases. Genetics 186, 757–761 (2010).
Fu, Y. et al. High-frequency off-target mutagenesis induced by CRISPR–Cas nucleases in human cells. Nature Biotech. 31, 822–826 (2013).
Wang, H. H. et al. Programming cells by multiplex genome engineering and accelerated evolution. Nature 460, 894–898 (2009).
Rios, X. et al. Stable gene targeting in human cells using single-strand oligonucleotides with modified bases. PLoS ONE 7, e36697 (2012).
Gibson, D. G., Smith, H. O., Hutchison, C. A., 3rd, Venter, J. C. & Merryman, C. Chemical synthesis of the mouse mitochondrial genome. Nature Methods 7, 901–903 (2010).
Dymond, J. S. et al. Synthetic chromosome arms function in yeast and generate phenotypic diversity by design. Nature 477, 471–476 (2011).
Schlabach, M. R., Hu, J. K., Li, M. & Elledge, S. J. Synthetic design of strong promoters. Proc. Natl Acad. Sci. USA 107, 2538–2543 (2010).
Patwardhan, R. P. et al. High-resolution analysis of DNA regulatory elements by synthetic saturation mutagenesis. Nature Biotech. 27, 1173–1175 (2009).
Kheradpour, P. et al. Systematic dissection of regulatory motifs in 2000 predicted human enhancers using a massively parallel reporter assay. Genome Res. 23, 800–811 (2013).
Melnikov, A. et al. Systematic dissection and optimization of inducible enhancers in human cells using a massively parallel reporter assay. Nature Biotech. 30, 271–277 (2012).
Patwardhan, R. P. et al. Massively parallel functional dissection of mammalian enhancers in vivo. Nature Biotech. 30, 265–270 (2012).
Smith, R. P. et al. Massively parallel decoding of mammalian regulatory sequences supports a flexible organizational model. Nature Genet. 45, 1021–1028 (2013). References 84–87 describe how massively parallel reporter assays can be used to study large libraries of synthetic variants of gene regulatory sequences.
Xu, G. L. & Bestor, T. H. Cytosine methylation targetted to pre-determined sequences. Nature Genet. 17, 376–378 (1997).
Maeder, M. L. et al. Targeted DNA demethylation and activation of endogenous genes using programmable TALE-TET1 fusion proteins. Nature Biotech. 31, 1137–1142 (2013).
Mendenhall, E. M. et al. Locus-specific editing of histone modifications at endogenous enhancers. Nature Biotech. 31, 1133–1136 (2013).
Hathaway, N. A. et al. Dynamics and memory of heterochromatin in living cells. Cell 149, 1447–1460 (2012). References 89–91 report the fusion of chromatin-modifying proteins to artificial DNA-binding factors, which can provide insight into how chromatin states are regulated.
Cantone, I. et al. A yeast synthetic network for in vivo assessment of reverse-engineering and modeling approaches. Cell 137, 172–181 (2009).
Kang, T. et al. Reverse engineering validation using a benchmark synthetic gene circuit in human cells. ACS Synth. Biol. 2, 255–262 (2013).
Shen-Orr, S. S., Milo, R., Mangan, S. & Alon, U. Network motifs in the transcriptional regulation network of Escherichia coli. Nature Genet. 31, 64–68 (2002).
Gerstein, M. B. et al. Architecture of the human regulatory network derived from ENCODE data. Nature 489, 91–100 (2012).
Kramer, B. P. & Fussenegger, M. Hysteresis in a synthetic mammalian gene network. Proc. Natl Acad. Sci. USA 102, 9517–9522 (2005).
Bleris, L. et al. Synthetic incoherent feedforward circuits show adaptation to the amount of their genetic template. Mol. Syst. Biol. 7, 519 (2011).
Pomerening, J. R., Kim, S. Y. & Ferrell, J. E. Jr. Systems-level dissection of the cell-cycle oscillator: bypassing positive feedback produces damped oscillations. Cell 122, 565–578 (2005).
Riccione, K. A., Smith, R. P., Lee, A. J. & You, L. A synthetic biology approach to understanding cellular information processing. ACS Synth. Biol. 1, 389–402 (2012).
James, J. R. & Vale, R. D. Biophysical mechanism of T-cell receptor triggering in a reconstituted system. Nature 487, 64–69 (2012). Recapitulates T cell signalling by heterologous expression of more than 10 pathway-associated proteins in a non-immune cell.
O'Shaughnessy, E. C., Palani, S., Collins, J. J. & Sarkar, C. A. Tunable signal processing in synthetic MAP kinase cascades. Cell 144, 119–131 (2011).
Gaudet, D. et al. Efficacy and long-term safety of alipogene tiparvovec (AAV1-LPLS447X) gene therapy for lipoprotein lipase deficiency: an open-label trial. Gene Ther. 20, 361–369 (2013).
Dalkara, D. et al. In vivo-directed evolution of a new adeno-associated virus for therapeutic outer retinal gene delivery from the vitreous. Sci. Transl. Med. 5, 189ra76 (2013).
Aiuti, A. et al. Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott–Aldrich syndrome. Science 341, 1233151 (2013).
Biffi, A. et al. Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy. Science 341, 1233158 (2013).
Perez, E. E. et al. Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases. Nature Biotech. 26, 808–816 (2008).
Gross, G., Waks, T. & Eshhar, Z. Expression of immunoglobulin–T-cell receptor chimeric molecules as functional receptors with antibody-type specificity. Proc. Natl Acad. Sci. USA 86, 10024–10028 (1989). The development of CAR technology.
Brentjens, R. J. et al. Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias. Blood 118, 4817–4828 (2011).
Kloss, C. C., Condomines, M., Cartellieri, M., Bachmann, M. & Sadelain, M. Combinatorial antigen recognition with balanced signaling promotes selective tumor eradication by engineered T cells. Nature Biotech. 31, 71–75 (2013).
Lanitis, E. Chimeric antigen receptor T cells with dissociated signaling domains exhibit focused antitumor activity with reduced potential for toxicity in vivo. Cancer Immunol. Res. http://dx.doi.org/10.1158/2326-6066.CIR-13-0008 (2013).
Chen, Y. Y., Jensen, M. C. & Smolke, C. D. Genetic control of mammalian T-cell proliferation with synthetic RNA regulatory systems. Proc. Natl Acad. Sci. USA 107, 8531–8536 (2010).
Wei, P. et al. Bacterial virulence proteins as tools to rewire kinase pathways in yeast and immune cells. Nature 488, 384–388 (2012). Shows that amplitude and pause switch devices that are based on bacterial virulence proteins can be used to modulate immune response of T cells.
Folcher, M. & Fussenegger, M. Synthetic biology advancing clinical applications. Curr. Opin. Chem. Biol. 16, 345–354 (2012).
Lim, F. & Sun, A. M. Microencapsulated islets as bioartificial endocrine pancreas. Science 210, 908–910 (1980).
Ye, H., Daoud-El Baba, M., Peng, R. W. & Fussenegger, M. A synthetic optogenetic transcription device enhances blood-glucose homeostasis in mice. Science 332, 1565–1568 (2011).
Ortiz-Sanchez, E., Helguera, G., Daniels, T. R. & Penichet, M. L. Antibody-cytokine fusion proteins: applications in cancer therapy. Expert Opin. Biol. Ther. 8, 609–632 (2008).
Byrne, H., Conroy, P. J., Whisstock, J. C. & O'Kennedy, R. J. A tale of two specificities: bispecific antibodies for therapeutic and diagnostic applications. Trends Biotechnol. 31, 621–632 (2013).
Cironi, P., Swinburne, I. A. & Silver, P. A. Enhancement of cell type specificity by quantitative modulation of a chimeric ligand. J. Biol. Chem. 283, 8469–8476 (2008).
Taylor, N. D., Way, J. C., Silver, P. A. & Cironi, P. Anti-glycophorin single-chain Fv fusion to low-affinity mutant erythropoietin improves red blood cell-lineage specificity. Protein Eng. Des. Sel. 23, 251–260 (2010).
Zelphati, O. et al. Intracellular delivery of proteins with a new lipid-mediated delivery system. J. Biol. Chem. 276, 35103–35110 (2001).
Akinc, A. et al. Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms. Mol. Ther. 18, 1357–1364 (2010).
Akinc, A. et al. A combinatorial library of lipid-like materials for delivery of RNAi therapeutics. Nature Biotech. 26, 561–569 (2008).
Kam, N. W., Liu, Z. & Dai, H. Functionalization of carbon nanotubes via cleavable disulfide bonds for efficient intracellular delivery of siRNA and potent gene silencing. J. Am. Chem. Soc. 127, 12492–12493 (2005).
Hasadsri, L., Kreuter, J., Hattori, H., Iwasaki, T. & George, J. M. Functional protein delivery into neurons using polymeric nanoparticles. J. Biol. Chem. 284, 6972–6981 (2009).
Lee, S. K., Han, M. S., Asokan, S. & Tung, C. H. Effective gene silencing by multilayered siRNA-coated gold nanoparticles. Small 7, 364–370 (2011).
Nishina, K. et al. Efficient in vivo delivery of siRNA to the liver by conjugation of alpha-tocopherol. Mol. Ther. 16, 734–740 (2008).
Rizk, S. S. et al. An engineered substance P variant for receptor-mediated delivery of synthetic antibodies into tumor cells. Proc. Natl Acad. Sci. USA 106, 11011–11015 (2009).
Bidwell, G. L., 3rd & Raucher, D. Cell penetrating elastin-like polypeptides for therapeutic peptide delivery. Adv. Drug Deliv. Rev. 62, 1486–1496 (2010).
Thompson, D. B., Cronican, J. J. & Liu, D. R. Engineering and identifying supercharged proteins for macromolecule delivery into mammalian cells. Methods Enzymol. 503, 293–319 (2012).
Cronican, J. J. et al. A class of human proteins that deliver functional proteins into mammalian cells in vitro and in vivo. Chem. Biol. 18, 833–838 (2011).
Dormitzer, P. R. et al. Synthetic generation of influenza vaccine viruses for rapid response to pandemics. Sci. Transl. Med. 5, 185ra68 (2013).
Coleman, J. R. et al. Virus attenuation by genome-scale changes in codon pair bias. Science 320, 1784–1787 (2008).
Mueller, S. et al. Live attenuated influenza virus vaccines by computer-aided rational design. Nature Biotech. 28, 723–726 (2010).
Geall, A. J., Mandl, C. W. & Ulmer, J. B. RNA: The new revolution in nucleic acid vaccines. Semin. Immunol. 25, 152–159 (2013).
Boudreau, J. E., Bonehill, A., Thielemans, K. & Wan, Y. Engineering dendritic cells to enhance cancer immunotherapy. Mol. Ther. 19, 841–853 (2011).
Huh, D. et al. A human disease model of drug toxicity-induced pulmonary edema in a lung-on-a-chip microdevice. Sci. Transl. Med. 4, 159ra147 (2012).
Greber, D. & Fussenegger, M. An engineered mammalian band-pass network. Nucleic Acids Res. 38, e174 (2010).
Galloway, K. E., Franco, E. & Smolke, C. D. Dynamically reshaping signaling networks to program cell fate via genetic controllers. Science 341, 1235005 (2013).
Nissim, L. & Bar-Ziv, R. H. A tunable dual-promoter integrator for targeting of cancer cells. Mol. Syst. Biol. 6, 444 (2010).
Papapetrou, E. P. et al. Genomic safe harbors permit high β-globin transgene expression in thalassemia induced pluripotent stem cells. Nature Biotech. 29, 73–78 (2011).
Themeli, M. et al. Generation of tumor-targeted human T lymphocytes from induced pluripotent stem cells for cancer therapy. Nature Biotech. 31, 928–933 (2013).
Carr, P. A. & Church, G. M. Genome engineering. Nature Biotech. 27, 1151–1162 (2009).
Gibson, D. G. et al. Enzymatic assembly of DNA molecules up to several hundred kilobases. Nature Methods 6, 343–345 (2009).
Guye, P., Li, Y., Wroblewska, L., Duportet, X. & Weiss, R. Rapid, modular and reliable construction of complex mammalian gene circuits. Nucleic Acids Res. 41, e156 (2013).
Torella, J. P. et al. Rapid construction of insulated genetic circuits via synthetic sequence-guided isothermal assembly. Nucleic Acids Res. http://dx.doi.org/10.1093/nar/gkt860 (2013).
Pathak, G. P., Vrana, J. D. & Tucker, C. L. Optogenetic control of cell function using engineered photoreceptors. Biol. Cell 105, 59–72 (2013).
The authors apologize to their colleagues whose work could not be cited owing to space limitations. They thank M. Inniss, J. Torella, T. Ford and J. Chen for helpful comments on the manuscript. The work in the author's laboratory was supported by: a European Molecular Biology Organization Fellowship and a Human Frontier Science Program Fellowship to F.L.; a Swiss National Science Foundation Fellowship to A.G.; and funds from NIH and the Defense Advanced Research Projects Agency to P.A.S.
- Digital logic gates
Idealized or physical devices that implement Boolean logic (such as AND, OR or NOT) on one or more inputs to produce a single output.
The combination of genetics and optics to control light-sensitive proteins within specific cells.
- Directed molecular evolution
A method that mimics the process of natural selection to evolve proteins or nucleic acids towards a user defined goal.
A system is orthogonal when changes to one component do not influence the other components.
Genetic engineering that is based on homologous recombination systems.
- Gene dosage compensation
Mechanisms that dampen fluctuations in gene expression levels in response to changes in gene copy numbers.
- Xenogeneic cells
Cells that belong to individuals of different species.
The immunologic reactions that occur when T cells are transplanted between two individuals of the same species.
About this article
Cite this article
Lienert, F., Lohmueller, J., Garg, A. et al. Synthetic biology in mammalian cells: next generation research tools and therapeutics. Nat Rev Mol Cell Biol 15, 95–107 (2014). https://doi.org/10.1038/nrm3738
Nature Reviews Materials (2021)
Scientific Reports (2021)
Quantitative Biology (2020)
Synthetic biology in various cellular and molecular fields: applications, limitations, and perspective
Molecular Biology Reports (2020)
Journal of Biological Engineering (2019)